These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 31982886

  • 1. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Mortimer KM, Bartels DB, Hartmann N, Capapey J, Yang J, Gately R, Enger C.
    Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
    [Abstract] [Full Text] [Related]

  • 2. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
    Mortimer K, Hartmann N, Chan C, Norman H, Wallace L, Enger C.
    BMC Pulm Med; 2019 Jan 10; 19(1):11. PubMed ID: 30630460
    [Abstract] [Full Text] [Related]

  • 3. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
    Yu YF, Wu N, Chuang CC, Wang R, Pan X, Benjamin NN, Devercelli G, Coultas DB.
    J Manag Care Spec Pharm; 2016 Apr 10; 22(4):414-23. PubMed ID: 27023695
    [Abstract] [Full Text] [Related]

  • 4. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL, Maher TM, Acciai V, Mounir B, Quaresma M, Zouad-Lejour L, Wells CD, De Loureiro L.
    Adv Ther; 2020 Jul 10; 37(7):3292-3298. PubMed ID: 32451950
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study.
    Raimundo K, Chang E, Broder MS, Alexander K, Zazzali J, Swigris JJ.
    BMC Pulm Med; 2016 Jan 05; 16():2. PubMed ID: 26732054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C.
    Dan Med J; 2015 Apr 05; 62(4):B5069. PubMed ID: 25872544
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Burden of illness in progressive fibrosing interstitial lung disease.
    Singer D, Bengtson LGS, Conoscenti CS, Anderson AJ, Brekke L, Shetty SS, Brown KK.
    J Manag Care Spec Pharm; 2022 Aug 05; 28(8):871-880. PubMed ID: 35876293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.
    Ley B, Urbania T, Husson G, Vittinghoff E, Brush DR, Eisner MD, Iribarren C, Collard HR.
    Ann Am Thorac Soc; 2017 Jun 05; 14(6):880-887. PubMed ID: 28355518
    [Abstract] [Full Text] [Related]

  • 16. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
    Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, Raghu G.
    Ann Am Thorac Soc; 2015 Jul 05; 12(7):981-7. PubMed ID: 25923447
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L.
    Adv Ther; 2021 Jul 05; 38(7):4100-4114. PubMed ID: 34156606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.